Needham & Company LLC Reaffirms “Buy” Rating for Autolus Therapeutics (NASDAQ:AUTL)
Needham & Company LLC reissued their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Thursday,Benzinga reports. Needham & Company LLC currently has a $10.00 price target on the stock. Several other analysts have also commented on the stock. Wells Fargo & Company lowered their price objective […]
Needham & Company LLC reissued their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Thursday,Benzinga reports. Needham & Company LLC currently has a $10.00 price target on the stock. Several other analysts have also commented on the stock. Wells Fargo & Company lowered their price objective […]
